source
- Proposed Biotech Investment National Security Act may protect US firms but contains loophole aiding Chinese competitionA bipartisan bill called the Biotech Investment National Security Act (BINSA) has been introduced in Congress to expand federal oversight of biotechnology activities, from drug development to biolo…
- DEA moves on kratom substances as FDA greenlights new pancreatic drugThe Drug Enforcement Administration is taking new steps concerning substances associated with kratom, signaling a shift in how the agency handles the plant-derived compounds. In a separate develop…